Sida e infección por VIH
Publicaciones destacadas
-
Bictegravir/emtricitabine/tenofovir alafenamide in clinical practice for people with HIV: final 24-month effectiveness and safety outcomes in key populations in the observational BICSTaR cohort
Trottier, B; Yang, CJ; Watanabe, D; Marchetti, G; Elbirt, D;(...)Heinzkill, M; Marongiu, A; Ramroth, J; D'Amato, L; Mallolas, J.Referencia:Hiv Research And Clinical Practice 2025.
-
The Role of Protease Inhibitors in HIV Treatment: Who Still Needs Them in 2025?
Sempere, Abiu; Alonso, Rodrigo; Berrocal, Leire; Calvo, Julia; Foncillas, Alberto;(...)Martinez, Esteban; Miro, Jose M; de Lazzari, Elisa; Mallolas, Josep; Ambrosioni, Juan.Referencia:Infectious Diseases And Therapy 2025.
-
Results of a fast-track HIV and hepatitis C screening protocol in Barcelona, Spain
Chivite, I; Guilera, V; Callau, P; Aguiló, R; de Lazzari, E;Merino, MJ; Diaz, L; Carrodeguas, A; González-Sánchez, JL; Mallolas, J.Referencia:Plos One 2025.
-
Long-Term Health Outcomes of People with HIV Engaged in Chemsex: A Prospective Cohort Study on Drug Use, Sexual Behaviour, Sexually-Transmitted Infections and Vulnerability
De la Mora, Lorena; Laguno, Montserrat; Torres, Berta; Chivite, Ivan; Foncillas, Alberto;(...)Miquel, Laia; Blanch, Jordi; Short, Duncan; Mallolas, Josep; Martinez-Rebollar, Maria.Referencia:Infectious Diseases And Therapy 2025.
-
Rapid initiation of bictegravir/emtricitabine/tenofovir alafenamide as first-line therapy in HIV infection. A prospective study
Ugarte, Ainoa; De La Mora, Lorena; De Lazzari, Elisa; Chivite, Ivan; Fernandez, Emma;(...)Calvo, Julia; Blanco, Jose Luis; Martinez, Esteban; Mallolas, Josep; Torres, Berta.Referencia:Journal Of Antimicrobial Chemotherapy 2024.
-
Toxic-Induced Encephalopathy Following Chemsex in a Young HIV-Positive Male: A Complex Case of Acute Cognitive Impairment with Anterograde Amnesia and Behavioral Alterations
Inciarte, Alexy; de la Mora, Lorena; Huaier-Arriazu, Emilio; Torres, Berta; Canizares, Silvia;(...)Martinez, Esteban; Blanco, Jose Luis; Miro, J M; Martinez-Rebollar, Maria; Mallolas, Josep.Referencia:Infectious Diseases And Therapy 2024.
-
Outcomes of Drug Interactions Between Antiretrovirals and Co-Medications, Including Over-the-Counter Drugs: A Real-World Study
Ambrosioni, J; Diaz, NA; Marzolini, C; Dragovic, G; Imaz, A;(...)Khoo, S; Burger, D; Cortes, CP; Naous, N; Molto, J.Referencia:Infectious Diseases And Therapy 2024.
-
Sex-based epidemiological and immunovirological characteristics of people living with HIV in current follow-up at a tertiary hospital: a comparative retrospective study, Catalonia, Spain, 1982 to 2020
Toyos, Sara; Berrocal, Leire; Gonzalez-Cordon, Ana; Inciarte, Alexy; de la Mora, Lorena;(...)Blanco, Jose Luis; Martinez, Esteban; Miro, Jose M; Mallolas, Josep; Torres, Berta.Referencia:Eurosurveillance 2023.
-
PrEP program experience in a hospital HIV unit. Description of baseline user profile and identification of opportunities for improvement
Laguno, Montserrat; Ugarte, Ainoa; Martinez-Rebollar, Maria; Sobrino, Yeray; Font, Guillermo;(...)Rojas, Jhon; Cordon, Encarna; Luis Blanco, Jose; Martinez, Esteban; Mallolas, Josep.Referencia:Enfermedades Infecciosas Y Microbiologia Clinica 2023.
-
Immunological and virological findings in a patient with exceptional post-treatment control: a case report
Climent, Nuria; Ambrosioni, Juan; Gonzalez, Tania; Xufre, Cristina; Casadella, Maria;(...)Grau-Exposito, Judith; Mallolas, Josep; Alcami, Jose; Sanchez-Palomino, Sonsoles; Miro, Jose M.Referencia:Lancet Hiv 2023.
